Eric Schadt

Eric Schadt
Name	Eric Schadt
Birth date	1965
Nationality	American
Fields	Bioinformatics, Systems biology, Computational biology, Genomics
Institutions	Mount Sinai Health System, Sage Bionetworks, Princeton University, Columbia University, New York University
Alma mater	Rensselaer Polytechnic Institute, University of California, Berkeley
Known for	Network biology, integrative genomics, population-scale molecular profiling

Eric Schadt is an American computational biologist and leader in network-based approaches to genomics and precision medicine. He is noted for integrating large-scale molecular datasets with clinical and population information to model disease mechanisms and for founding and leading organizations bridging academic research and biotechnology. His career spans academic appointments, start-up ventures, and roles in pharmaceutical and health technology sectors.

Early life and education

Schadt was born in 1965 and raised in the United States, later pursuing undergraduate studies at Rensselaer Polytechnic Institute where he received training in mathematics and computer science. He completed his doctoral work at the University of California, Berkeley focusing on computational analysis relevant to molecular biology. During his formative years he trained in interdisciplinary environments connecting laboratories such as those at Cold Spring Harbor Laboratory and computational centers like Lawrence Berkeley National Laboratory.

Academic career and research

Schadt held faculty positions at institutions including New York University and Columbia University before joining the faculty at Mount Sinai Health System. His research built on methods from Bayesian statistics, machine learning, and network theory to construct gene and molecular interaction networks derived from high-throughput data such as microarray and next-generation sequencing. He collaborated with consortia and projects like the Human Genome Project, ENCODE Project, and population cohorts such as the Framingham Heart Study and UK Biobank to link molecular variation to clinical phenotypes. His laboratories developed software and analytic frameworks that interfaced with resources including Gene Expression Omnibus, The Cancer Genome Atlas, and pathway databases like KEGG and Reactome.

Industry leadership and entrepreneurship

Schadt founded and led biotechnology companies that translated network genomics into drug discovery and precision health platforms, engaging investors and partners from the biotechnology and pharmaceutical sectors such as Genentech, Amgen, Pfizer, and venture firms tied to Sequoia Capital and New Enterprise Associates. He served in executive roles at organizations including Sage Bionetworks and later as chief scientific officer and then chief executive at analytics-driven enterprises collaborating with technology companies like Google and Amazon Web Services. His industry work emphasized integration with electronic health record initiatives around Mount Sinai Health System and partnerships with health data efforts such as All of Us Research Program.

Major contributions and scientific impact

Schadt pioneered the application of network inference to identify key drivers of complex diseases including Alzheimer's disease, type 2 diabetes, schizophrenia, and various cancer types, combining transcriptomic, proteomic, and metabolomic datasets. His publications advanced concepts in causal modeling and systems-level biomarker discovery, influencing fields represented by organizations like the National Institutes of Health, Howard Hughes Medical Institute, and the Broad Institute. He promoted open-science practices through data-sharing platforms modeled after The Cancer Genome Atlas and contributed analytic tools that interfaced with community resources such as Bioconductor and GitHub for reproducible computational biology.

Awards and honors

Schadt's work has been recognized by awards and appointments from academic and professional bodies including fellowships and advisory roles with institutions like the American Association for the Advancement of Science, the National Academy of Medicine advisory panels, and prizes from genomic and bioinformatics societies. He has been invited to deliver named lectures at venues including Cold Spring Harbor Laboratory symposia, Keystone Symposia, and meetings hosted by the American Society of Human Genetics.

Personal life and philanthropy

Outside of his professional roles, Schadt has engaged in philanthropic activities supporting research infrastructures and education initiatives tied to institutions such as Princeton University, Rensselaer Polytechnic Institute, and community health projects in the New York City area. He has participated in advisory boards for non-profit research organizations and foundations that fund translational genomics and data-driven medicine.

Category:American bioinformaticians Category:1965 births Category:Living people